Early onset of changes to the reproductive system of Fasciola hepatica following in vivo treatment with triclabendazole

Veterinary Parasitology

Volumn 184, Issue 2-4, 2012, Pages 341-347

  Hanna, R E B ^a   Scarcella, S ^b   Solana, H ^b   McConnell, S ^a   Fairweather, I ^c  

^a AGRI FOOD AND BIOSCIENCES INSTITUTE   (United Kingdom)

^b UNIVERSIDAD NACIONAL DEL CENTRO DE LA PROVINCIA DE BUENOS AIRES   (Argentina)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Fasciola hepatica; Histology; In vivo; Liver fluke; Mehlis' gland; Ovary; Testis; Time course in sheep host; Triclabendazole; Uterus; Vitellaria

Indexed keywords

TRICLABENDAZOLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL VACUOLE; CONTROLLED STUDY; FASCIOLA HEPATICA; FASCIOLIASIS; GENITAL SYSTEM; HISTOLOGY; IN VIVO STUDY; LAMB; LIVER; MEHLIS GLAND; NONHUMAN; OVARY; SPERMATOCYTE; TESTIS; UTERUS; VITELLARIA; VITELLINE MEMBRANE; WORM EGG;

ANIMALS; ANTHELMINTICS; BENZIMIDAZOLES; FASCIOLA HEPATICA; FASCIOLIASIS; GONADS; LIVER; SHEEP; SHEEP DISEASES; TIME FACTORS;

FASCIOLA HEPATICA; OVIS ARIES; VITELLARIA;

EID: 84855973584     PISSN: 03044017     EISSN: 18732550     Source Type: Journal    
DOI: 10.1016/j.vetpar.2011.08.023     Document Type: Article

References (35)

1. AVMA, 2001. Report of the AVMA Panel on Euthanasia. J. Am. Vet. Med. Assoc. 218, 669-696.
2. Büscher G., Bowen F.L., Strong M.B., Allison J.R., Richards R.J. Extension of the prepatent period of Fasciola hepatica in infected animals following treatment with triclabendazole. Vet. Rec. 1987, 120:460-461.
3. Colhoun L.M., Fairweather I., Brennan G.P., Woods M.M. Observations on the mechanism of eggshell formation in the liver fluke, Fasciola hepatica. Parasitology 1998, 116:555-567.
4. Dawes B. Some apparent effects of bithionol (Actamer) on Fasciola hepatica. Nature 1966, 209:424-425.
5. Dawes B. Experimental fascioliasis: some effects on Fasciola hepatica of treatment of rat hosts with bithionol (Actamer). Helminthologia 1966, 7:297-307.
6. Dawes B. Experimental fascioliasis in small mammals: apparent effects of bithionol on Fasciola hepatica in rats. Helminthologia 1967, 8:97-101.
7. Dawes B. Further evidence on the effect of bithionol (Actamer) on Fasciola hepatica. Wiad. Parazytol. 1968, 14:575-577.
8. Fairweather I. Triclabendazole: new skills to unravel an old(ish) enigma. J. Helminthol. 2005, 79:227-234.
9. Fairweather I. Triclabendazole progress report, 2005-2009: an advancement of learning?. J. Helminthol. 2009, 83:139-150.
10. Fairweather I. Liver fluke isolates: a question of provenance. Vet. Parasitol. 2011, 176:1-8.
11. Fairweather I. Raising the bar on reporting triclabendazole resistance. Vet. Rec. 2011, 168:514-515.
12. Fairweather I. Reducing the future threat from (liver) fluke: realistic prospect or quixotic fantasy?. Vet. Parasitol. 2011, 180:133-143.
13. Fairweather I., Anderson H.R., Threadgold L.T. Fasciola hepatica: morphological changes in vitelline cells following treatment in vitro with the deacetylated (amine) metabolite of diamphenethide (DAMD). Int. J. Parasitol. 1988, 18:1061-1069.
14. Fairweather I., Threadgold L.T., Hanna R.E.B. Development of Fasciola hepatica in the mammalian host. Fasciolosis 1999, 47-111. CAB International, Wallingford, Oxon. J.P. Dalton (Ed.).
15. Flanagan A., Edgar H.W.J., Gordon A., Hanna R.E.B., Brennan G.P., Fairweather I. Comparison of two assays, a faecal egg count reduction test (FECRT) and a coproantigen reduction test (CRT), for the diagnosis of resistance to triclabendazple in Fasciola hepatica in sheep. Vet. Parasitol. 2011, 176:170-176.
16. Halferty L., Brennan G.P., Hanna R.E.B., Edgar H.W., Meaney M., McConville M., Trudgett A., Hoey L., Fairweather I. Tegumental surface changes in juvenile Fasciola hepatica in response to treatment in vivo with triclabendazole. Vet. Parasitol. 2008, 155:49-58.
17. Hanna R.E.B., Cromie L., Taylor S.M., Couper A. The effect of a parenteral ivermectin/closantel injection on the growth and reproductive development of early immature Fasciola hepatica in cattle. Vet. Parasitol. 2006, 142:78-90.
18. Hanna R.E.B., Edgar H., Moffett D., McConnell S., Fairweather I., Brennan G.P., Trudgett A., Hoey E.M., Cromie L., Taylor S.M., Daniel R. Fasciola hepatica: histology of the testis in egg-producing adults of several laboratory-maintained isolates of flukes grown to maturity in cattle and sheep and in flukes from naturally infected hosts. Vet. Parasitol. 2008, 157:222-234.
19. Hanna R.E.B., Edgar H.W.J., McConnell S., Toner E., McConville M., Brennan G.P., Devine C., Flanagan A., Halferty L., Meaney M., Shaw L., Moffett D., McCoy M., Fairweather I. Fasciola hepatica: histological changes in the reproductive structures of triclabendazole (TCBZ)-sensitive and TCBZ-resistant flukes after treatment in vivo with TCBZ and the related benzimidazole derivative, Compound Alpha. Vet. Parasitol. 2010, 168:240-254.
20. Lang B.Z., Hall R.F., Kirstein K.W., Wescott R.B. Reduced reproductive potential of Fasciola hepatica surviving in cattle treated with albendazole. Vet. Med. Small Anim. Clin. 1980, 75:1853-1857.
21. Maes L., Lauwers H., Deckers W., Vanparijs O. Flukicidal action of closantel against immature and mature Fasciola hepatica in experimentally infected rats and sheep. Res. Vet. Sci. 1988, 44:229-232.
22. Maes L., Vanparijs O., Lauwers H., Deckers W. Comparative efficacy of closantel and triclabendazole against Fasciola hepatica in experimentally infected sheep. Vet. Rec. 1990, 127:450-452.
23. Malone J.B., Ramsey R.T., Loyacano A.F. Efficacy of clorsulon for treatment of mature naturally acquired and 8-week-old experimentally induced Fasciola hepatica infections in cattle. Am. J. Vet. Res. 1984, 45:851-854.
24. McConville M., Hanna R.E.B., Brennan G.P., McCoy M., Edgar H.W.J., McConnell S., Castillo R., Hernández-C A., Fairweather I. Fasciola hepatica: disruption of spermatogenesis by the fasciolicide compound alpha. Parasitol. Res. 2010, 106:311-323.
25. Skuce P.J., Fairweather I. The effect of the hydrogen ionophore closantel upon the pharmacology and ultrastructure of the adult liver fluke Fasciola hepatica. Parasitol. Res. 1990, 76:241-250.
26. Solana H.D., Rodriguez J.A., Lanusse C.E. Comparative metabolism of albendazole and albendazole sulphoxide by different helminth parasites. Parasitol. Res. 2001, 87:275-280.
27. Stammers B.M. The effects of rafoxanide and nitroxynil on the survival, growth and morphology of Fasciola hepatica in rabbits. Z. Parasitenkd. 1975, 46:153-164.
28. Stammers B.M. Disruption of spermatogenesis in Fasciola hepatica by some anthelmintics. Z. Parasitenkd. 1975, 47:145-150.
29. Stammers B.M. The effects of nitroxynil on the survival, growth and morphology of Fasciola hepatica in sheep. Res. Vet. Sci. 1976, 20:174-179.
30. Stitt A.W., Fairweather I. Spermatogenesis in Fasciola hepatica: an ultrastructural comparison of the effects of the anthelmintic, triclabendazole (Fasinex) and the microtubule inhibitor, tubulozole. Invertebr. Reprod. Dev. 1992, 22:139-150.
31. Stitt A.W., Fairweather I. Fasciola hepatica: disruption of the vitelline cells in vitro by the sulphoxide metabolite of triclabendazole. Parasitol. Res. 1996, 82:333-339.
32. Toner E., Brennan G.P., Hanna R.E.B., Edgar H.W., Fairweather I. Tegumental surface changes in adult Fasciola hepatica in response to treatment in vivo with triclabendazole in the sheep host. Vet. Parasitol. 2010, 172:238-248.
33. Toner E., Brennan G.P., Hanna R.E.B., Edgar H.W.J., Fairweather I. Time-dependent changes to the tegumental system and gastrodermis of adult Fasciola hepatica following treatment in vivo with triclabendazole in the sheep host. Vet. Parasitol. 2010, 174:218-227.
34. Toner E., Brennan G.P., Hanna R.E.B., Edgar H.W.J., Fairweather I. Disruption of egg formation by Fasciola hepatica following treatment in vivo with triclabendazole in the sheep host. Vet. Parasitol. 2011, 177:79-89.
35. Toner E., Brennan G.P., Hanna R.E.B., Edgar H.W.J., Fairweather I. Fasciola hepatica: time-dependent disruption of spermatogenesis following in vivo treatment with triclabendazole. Parasitol. Res. 2011, 109:1035-1043.